{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:06:06Z","timestamp":1791302766635,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.autrev.2010.09.016","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T08:45:31Z","timestamp":1285145131000},"page":"276-281","source":"Crossref","is-referenced-by-count":129,"title":["Fibrosis and immune dysregulation in systemic sclerosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Carlo","family":"Chizzolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2 C.","family":"Brembilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2010.09.016_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1357-2725(96)00115-X","article-title":"Mechanisms of tissue repair: from wound healing to fibrosis","volume":"29","author":"Mutsaers","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00870304","article-title":"T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples","volume":"21","author":"Chizzolini","year":"1999","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/07853890601098152","article-title":"Update on pathophysiology of scleroderma with special reference to immunoinflammatory events","volume":"39","author":"Chizzolini","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2010.09.016_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-2-200401200-00013","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00002281-200011000-00007","article-title":"Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon","volume":"12","author":"Tan","year":"2000","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2010.09.016_bb0035","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2189","article-title":"Genetic factors in systemic sclerosis","volume":"9","author":"Mayes","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2010.09.016_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s001090050216","article-title":"Pathogenesis of fibrosis: type 1 collagen and the skin","volume":"76","author":"Trojanowska","year":"1998","journal-title":"J Mol Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0045","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/1529-0131(199707)40:7<1237::AID-ART7>3.0.CO;2-Y","article-title":"Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis","volume":"40","author":"Shi-Wen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1523-1747.2001.01256.x","article-title":"Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1","volume":"116","author":"Shi-Wen","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(92)80064-N","article-title":"Interleukin-6 expression by fibroblasts grown in three-dimensional gel cultures","volume":"298","author":"Eckes","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2010.09.016_bb0060","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/1521-4141(2001010)31:10<2936::AID-IMMU2936>3.0.CO;2-0","article-title":"High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts","volume":"31","author":"Yamamoto","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.0906-6705.2004.00222.x","article-title":"High plasminogen activator inhibitor type 2 expression is a hallmark of scleroderma fibroblasts in vitro","volume":"13","author":"Kessler-Becker","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/1523-1747.ep12318465","article-title":"Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis","volume":"105","author":"Igarashi","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0075","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/1529-0131(199811)41:11<2039::AID-ART20>3.0.CO;2-1","article-title":"Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts","volume":"41","author":"Chizzolini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0080","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/art.11129","article-title":"Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha","volume":"48","author":"Chizzolini","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0085","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1002\/art.20658","article-title":"Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts","volume":"50","author":"Mori","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0090","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.20225","article-title":"An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma","volume":"50","author":"Pannu","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0095","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.10413","article-title":"Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis","volume":"46","author":"Varga","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0100","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.11157","article-title":"Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts","volume":"48","author":"Mori","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI16269","article-title":"Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts","volume":"113","author":"Asano","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2010.09.016_bb0110","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/art.23698","article-title":"Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate","volume":"58","author":"Pannu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0115","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.20996","article-title":"Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta","volume":"52","author":"Bhattacharyya","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0120","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)62362-0","article-title":"Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts","volume":"166","author":"Mimura","year":"2005","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2010.09.016_bb0125","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S0923-1811(00)00143-2","article-title":"Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases","volume":"24","author":"Uitto","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2010.09.016_bb0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"Faseb J"},{"key":"10.1016\/j.autrev.2010.09.016_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0022-202X.2003.22133.x","article-title":"Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma","volume":"122","author":"Leask","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0140","doi-asserted-by":"crossref","first-page":"L1217","DOI":"10.1152\/ajplung.00020.2008","article-title":"EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis","volume":"294","author":"Hardie","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1523-1747.ep12462185","article-title":"Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts","volume":"96","author":"Mauviel","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0150","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1016\/S0021-9258(18)60642-8","article-title":"Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts","volume":"263","author":"Solis-Herruzo","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2010.09.016_bb0155","doi-asserted-by":"crossref","first-page":"30226","DOI":"10.1074\/jbc.M005310200","article-title":"Tumor necrosis factor-alpha inhibits transforming growth factor-beta \/Smad signaling in human dermal fibroblasts via AP-1 activation","volume":"275","author":"Verrecchia","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2010.09.016_bb0160","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.4049\/jimmunol.171.7.3855","article-title":"Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts","volume":"171","author":"Yamane","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0165","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/art.1780290706","article-title":"Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels","volume":"29","author":"Rosenbloom","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0170","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI116015","article-title":"Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4","volume":"90","author":"Postlethwaite","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2010.09.016_bb0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/1523-1747.ep12319207","article-title":"Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures","volume":"109","author":"Serpier","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(24)35380-7","article-title":"Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts","volume":"292","author":"Oriente","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.autrev.2010.09.016_bb0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0190","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1523-1747.ep12560826","article-title":"Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization","volume":"90","author":"Kahari","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","article-title":"Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization","volume":"18","author":"Scharffetter","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.autrev.2010.09.016_bb0200","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1096\/fj.01-0306fje","article-title":"Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions","volume":"15","author":"Hoffmann","year":"2001","journal-title":"Faseb J"},{"key":"10.1016\/j.autrev.2010.09.016_bb0205","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.4049\/jimmunol.171.7.3655","article-title":"Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair","volume":"171","author":"Sandler","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0210","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2249.1990.tb08094.x","article-title":"Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis","volume":"79","author":"Ferrarini","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0225","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780400321","article-title":"Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage","volume":"40","author":"Gruschwitz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0230","first-page":"1751","article-title":"Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0235","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.132.7.802","article-title":"Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis","volume":"132","author":"Salmon-Ehr","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0240","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10049","article-title":"Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens","volume":"46","author":"Scaletti","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0245","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","article-title":"Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis","volume":"42","author":"Atamas","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0250","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1165\/ajrcmb.26.5.4683","article-title":"Gene expression in bronchoalveolar lavage cells from scleroderma patients","volume":"26","author":"Luzina","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0255","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0260","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.23406","article-title":"T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease","volume":"58","author":"Boin","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0265","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1002\/art.22877","article-title":"T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro","volume":"56","author":"Del Galdo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0198-8859(96)00091-2","article-title":"Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis","volume":"48","author":"Yurovsky","year":"1996","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0275","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0280","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","article-title":"Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0285","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0290","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2010.09.016_bb0295","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ncprheum0618","article-title":"Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma","volume":"3","author":"Deleuran","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0300","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0305","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2010.09.016_bb0310","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.24432","article-title":"Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis","volume":"60","author":"Fuschiotti","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0315","first-page":"2015","article-title":"IL13RA2 gene polymorphisms are associated with systemic sclerosis","volume":"33","author":"Granel","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0320","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20020906","article-title":"Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2","volume":"197","author":"Wood","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0325","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0330","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1023\/A:1011024313525","article-title":"Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation","volume":"21","author":"Valentini","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0335","first-page":"739","article-title":"Polarized subsets of human T helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts (Abstract)","volume":"23","author":"Chizzolini","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0340","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4049\/jimmunol.159.3.1437","article-title":"The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis","volume":"159","author":"Keane","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0345","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.4049\/jimmunol.164.12.6174","article-title":"Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop","volume":"164","author":"Yamamoto","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0350","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000094242","article-title":"Chemokines and chemokine receptors in scleroderma","volume":"140","author":"Yamamoto","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0355","first-page":"SIII110","article-title":"MCP-1 stimulates the release of the profibrotic cytokine IL-4 by inducing Th2 differentiation in Th0 cells (Abstract)","volume":"64","author":"Distler","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2010.09.016_bb0360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0923-1811(00)00169-9","article-title":"Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis","volume":"26","author":"Yamamoto","year":"2001","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2010.09.016_bb0365","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/35006097","article-title":"Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1","volume":"404","author":"Gu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2010.09.016_bb0370","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.4049\/jimmunol.163.4.2193","article-title":"Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models","volume":"163","author":"Hogaboam","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0375","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.168.6.2953","article-title":"IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling","volume":"168","author":"Zhu","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0380","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cyto.2003.08.003","article-title":"CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis","volume":"24","author":"Gharaee-Kermani","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2010.09.016_bb0385","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1165\/ajrcmb.22.3.3850","article-title":"B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis","volume":"22","author":"Rizou","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0390","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/art.10977","article-title":"Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis","volume":"48","author":"Hu","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0395","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","article-title":"Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis","volume":"120","author":"Sato","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0400","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2004.02615.x","article-title":"Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis","volume":"138","author":"Nishijima","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0405","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2249.2004.02633.x","article-title":"Autoantibodies to a collagen-specific molecular chaperone, heat-shock protein 47, in systemic sclerosis","volume":"138","author":"Fujimoto","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0410","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1529-0131(200011)43:11<2464::AID-ANR13>3.0.CO;2-F","article-title":"Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles","volume":"43","author":"Tan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0415","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4049\/jimmunol.163.2.1066","article-title":"Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases","volume":"163","author":"Tan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0420","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/jaut.2000.0362","article-title":"Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome","volume":"14","author":"Lundberg","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2010.09.016_bb0425","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-3083.2000.00733.x","article-title":"Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome","volume":"51","author":"Morse","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0430","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/08916939808996283","article-title":"Spontaneous occurrence of anti-fibrillin-1 autoantibodies in tight-skin mice","volume":"28","author":"Murai","year":"1998","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2010.09.016_bb0435","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.175.7.4555","article-title":"Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the \u201cscleroderma phenotype\u201d","volume":"175","author":"Zhou","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0440","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.171.12.6883","article-title":"A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies","volume":"171","author":"Yasuoka","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0445","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","article-title":"Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension","volume":"28","author":"Tamby","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2010.09.016_bb0450","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.20515","article-title":"Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis","volume":"50","author":"Henault","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0455","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.21646","article-title":"DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients","volume":"54","author":"Henault","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0460","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0465","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.0030002","article-title":"Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach","volume":"3","author":"Lunardi","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0470","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0475","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2007-01-071043","article-title":"Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease","volume":"110","author":"Svegliati","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2010.09.016_bb0480","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","article-title":"Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis","volume":"60","author":"Classen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0485","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","article-title":"Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera","volume":"60","author":"Loizos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0490","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","article-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","volume":"46","author":"Chizzolini","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0495","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/rheumatology\/kem241","article-title":"Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts","volume":"46","author":"Fineschi","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2010.09.016_bb0500","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/art.24049","article-title":"Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4","volume":"58","author":"Fineschi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0505","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2006-06-032961","article-title":"Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria","volume":"109","author":"Elson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2010.09.016_bb0510","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.179.9.6107","article-title":"TLR4\/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock","volume":"179","author":"Daubeuf","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0515","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2000-1-1-research002","article-title":"Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4)","volume":"1","author":"Smirnova","year":"2000","journal-title":"Genome Biol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0520","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.immunol.22.012703.104514","article-title":"Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease","volume":"25","author":"Marshak-Rothstein","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0525","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","article-title":"Toll-like receptors in systemic autoimmune disease","volume":"6","author":"Marshak-Rothstein","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0530","doi-asserted-by":"crossref","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma","author":"Yoshizaki","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2010.09.016_bb0535","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2010.09.016_bb0540","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ard.2006.065037","article-title":"Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies","volume":"66","author":"Pierangeli","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2010.09.016_bb0545","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2005-03-024463","article-title":"The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies","volume":"109","author":"Satta","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2010.09.016_bb0550","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1371\/journal.pmed.0030358","article-title":"In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes","volume":"3","author":"Zanoni","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2010.09.016_bb0555","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2010.09.016_bb0560","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0565","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.23451","article-title":"Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma","volume":"58","author":"Duan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0570","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/gene.2008.98","article-title":"Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers","volume":"10","author":"Bos","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2010.09.016_bb0575","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.09.016_bb0580","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","article-title":"Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis","volume":"58","author":"Kim","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:57:40Z","timestamp":1740527860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997210002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1568997210002120"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2010.09.016","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}